Stockreport

Meridian Bioscience offers SARS-CoV-2 antigens for COVID-19 Antibody Tests

Meridian Bioscience Inc.  (VIVO) 
Last meridian bioscience inc. earnings: 2/7 07:25 am Check Earnings Report
US:NASDAQ Investor Relations: investor.meridianbioscience.com
PDF CINCINNATI, April 14, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), announced today the launch of several novel recombinant antigens critical for [Read more]